<DOC>
	<DOCNO>NCT01042652</DOCNO>
	<brief_summary>This pilot randomize control Open-label trial compare raltegravir nevirapine anchor Drug combine antiretroviral therapy ( ART ) ART-naive HIV+ Chinese injection drug user also methadone maintenance therapy . The investigator hypotheses include : 1 . In raltegravir arm compare nevirapine arm , few patient require methadone dose adjustment abate methadone withdrawal symptom . Also average methadone dose achieve adequate serum methadone concentration patient raltegravir-based regimen low compare patient nevirapine-based regimen . 2 . Clinical outcome term viral suppression , CD4 recovery occurrence opportunistic infection comparable two arm 6 month one year . 3 . Patients raltegravir arm similar well side effect profile , retention rate , treatment adherence compare nevirapine arm .</brief_summary>
	<brief_title>A Trial Compare Raltegravir Versus Nevirapine Anchor Drug HIV+ Chinese IDUs Methadone Maintenance</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Chinese IDUs document HIV1 infection confirm western blot assay . On stable methadone maintenance therapy time enrollment . Antiretrovial treatment na√Øve meeting clinical criterion Chinese national guideline initiate antiretroviral therapy . Patient reproductive potential agrees use acceptable method birth control throughout study . Acceptable method birth control define intrauterine device ( IUD ) , diaphragm spermicide , condom , abstinence . Patients allergies contraindication select ARV regimen . Patients acute HIV infection . Use concomitant therapy potentially interact methadone schedule ARVs . Females pregnant , breastfeeding , plan get pregnant within study period use ineffective hormonal birth control . ( Note : All female patient must negative pregnancy test Treatment Day 1 ) Any active clinically significant disease finding discover screen medical history , physical examination laboratory assessment resolve stabilize within 30 day screen phase study . Patients clinical laboratory evidence active liver disease , severe hepatic impairment /dysfunction cirrhosis elevate liver enzyme level . ( Note : patient coinfected chronic hepatitis B C allow enter program condition judge clinically stable . ) Patient 's education level would interfere medical , adherence withdrawal symptom evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Methadone</keyword>
	<keyword>HIV</keyword>
	<keyword>Raltegravir</keyword>
	<keyword>Antiretroviral</keyword>
	<keyword>Intravenous Drug User</keyword>
	<keyword>Methadone Maintenance</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>